Table 2.
Patient | Ocular Phenotype | Non-ocular phenotype | Region | Copy state | Position | Size (Mb)a | Genes in region | Phenotype for gene/region | Significance for ocular disease |
---|---|---|---|---|---|---|---|---|---|
Patient 5 | B severe microphthalmia | None | 3q29 | Gain | 195383130–197550799 | 2.2 (1018) | SDHAP2, MUC20, MUC4, MIR570, TNK2, SDHAP1, TFRC, LOC401109, ZDHHC19, SLC51A, PCYT1A, TCTEX1D2, TM4SF19-TCTEX1D2, TM4SF19, UBXN7, RNF168, C3orf43, WDR53, FBXO45, LRRC33, CEP19, PIGX, PAK2, SENP5, NCBP2, LOC152217, PIGZ, MFI2-AS1, MFI2, DLG1, MIR4797, DLG1-AS1, BDH1, LOC220729, KIAA0226, MIR922, FYTTD1, LRCH3 | 3q29 duplication syndrome: developmental delay, obesity, heart defects, microcephaly, variable other features | Ocular anomalies (A/M, anterior segment dysgenesis) occasionally reported |
Patient 6b | B microphthalmia, congenital cataract, glaucoma, retinal detachment, optic nerve hypoplasia | Mild microcephaly, hypotonia, history of gross motor delay, pituitary hypoplasia, ADHD | 11p13 | Gain | 31609664–32486962 | 0.88 (707) | ELP4, PAX6, DKFZp686K1684, RCN1, WT1, WT1-AS | Variable ocular defects (typically mild), facial dysmorphism, other features | Mice with Pax6 overexpression show embryonic eye defects |
Patient 7b | R microphthalmia, iris coloboma, corneal leukoma | Neurofibromatosis type 1; B clinodactyly, redundant periumbilical skin | 17q11.2 | Loss | 28997779–30420528 | 1.4 (621) | SUZ12P1, CRLF3, CORPS, ATAD5, TEFM, ADAP2, RNF135, DPRXP4, MIR4733, NF1, OMG, EVI2B, EVI2A, RAB11FIP4, MIR4724, MIR193A, MIR4725, MIR365B, UTP6, SUZ12, LRRC37B, SH3GL1P1 | Neurofibromatosis type 1 | Ocular anomalies in some patients; Nf1 mutant mice have embryonic eye defects |
Patient 8b | B microphthalmia, microcornea, congenital cataract | Microcephaly, developmental delays, short stature | 2q14.2 | Gain | 120078243–120623545 | 0.55 (298) | C2orf76, DBI, TMEM37, SCTR, PCDP1, TMEM177, PTPN4 | None | Nanophthalmos 3 locus; TMEM37, ptpn4a, dbi are expressed in lens |
Patient 9 | B anophthalmia | Choanal atresia, broad nasal bridge, indented nasal tip | 2q21.1 | Gain | 130783696–131157859 | 0.37 (111) | POTEF CCDC74B-AS1, CCDC74B, SMPD4, MZT2B, TUBA3E CCDC115, IMP4, PTPN18 | None | SMPD4 enriched in the lens in mouse embryos |
Patient 10 | R severe microphthalmia | None | 15q26.3 | Gain | 102025982–102311246 | 0.29 (183) | PCSK6, TM2D3, TARSL2 | Levy-Shanske (tetrasomy): facial dysmorphism, craniosynostosis and other defects | PCSK6 is enriched in the lens in mouse embryos |
number of probes indicative of CNV is specified in parentheses;
familial cases (details are provided in the text); regions/genes associated with likely pathogenic variants are shown in bold